mk2 Biotech­nolo­gies is sup­port­ed by the Bavar­i­an Min­istry of Eco­nom­ic Affairs and Media, Ener­gy and Tech­nol­o­gy through the fund­ing pro­gram FLÜGGE. The com­pe­tent jury con­sid­ered the inno­v­a­tive pep­tide syn­the­sis tech­nol­o­gy by mk2 Biotech­nolo­gies to pro­vide out­stand­ing oppor­tu­ni­ties for sev­er­al appli­ca­tions. The tech­no­log­i­cal advances of simul­ta­ne­ous high puri­ties, authen­tic amino acid sequences and scal­a­bil­i­ty, which allow the syn­the­sis of high qual­i­ty pep­tides at low cost, are of excep­tion­al inter­est for the broad sci­en­tif­ic and indus­tri­al life sci­ences com­mu­ni­ty.

The FLÜGGE sup­port sup­ple­ments the grate­ful­ly acknowl­edged coop­er­a­tion with the Zei­dler-Forschungs-Stiftung and will allow the con­tin­u­a­tion of the mk2 Biotech­nolo­gies suc­cess sto­ry. Learn more about the appli­ca­tions of our dis­rup­tive tech­nol­o­gy here.